N
Nancy E. Clapp-Channing
Researcher at Duke University
Publications - 42
Citations - 9185
Nancy E. Clapp-Channing is an academic researcher from Duke University. The author has contributed to research in topics: Social support & Coronary artery disease. The author has an hindex of 27, co-authored 42 publications receiving 8694 citations. Previous affiliations of Nancy E. Clapp-Channing include Durham University & Medtronic plc.
Papers
More filters
Journal ArticleDOI
Amiodarone or an implantable cardioverter-defibrillator for congestive Heart failure
Gust H. Bardy,Kerry L. Lee,Daniel B. Mark,Jeanne E. Poole,Douglas L. Packer,Robin Boineau,Michael J. Domanski,Charles Troutman,Jill Anderson,Steven McNulty,Nancy E. Clapp-Channing,Linda Davidson-Ray,Elizabeth S. Fraulo,Daniel P. Fishbein,Richard M. Luceri,John Ip +15 more
TL;DR: In patients with NYHA class II or III CHF and LVEF of 35 percent or less, amiodarone has no favorable effect on survival, whereas single-lead, shock-only ICD therapy reduces overall mortality by 23 percent.
Journal ArticleDOI
Characteristics of socially isolated patients with coronary artery disease who are at elevated risk for mortality.
Beverly H. Brummett,John C. Barefoot,Ilene C. Siegler,Nancy E. Clapp-Channing,Barbara L. Lytle,Hayden B. Bosworth,Redford B. Williams,Daniel B. Mark +7 more
TL;DR: Patients with small social networks had an elevated risk of mortality, but this greater risk was not attributable to confounding with disease severity, demographics, or psychological distress.
Journal ArticleDOI
Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States.
Daniel B. Mark,CD Naylor,Mark A. Hlatky,Robert M. Califf,Eric J. Topol,Christopher B. Granger,Knight Jd,Charlotte L. Nelson,Kerry L. Lee,Nancy E. Clapp-Channing +9 more
TL;DR: The Canadian patients had more cardiac symptoms and worse functional status one year after acute myocardial infarction than the U.S. patients, and it is suggested that the more aggressive pattern of care in the United States may have been responsible for the better quality of life.
Journal ArticleDOI
Home Use of Automated External Defibrillators for Sudden Cardiac Arrest
Gust H. Bardy,Kerry L. Lee,Daniel B. Mark,Jeanne E. Poole,William D. Toff,Andrew Tonkin,Warren Smith,Paul Dorian,Douglas L. Packer,Roger D. White,William T. Longstreth,Jill Anderson,George Johnson,Eric Bischoff,Julie Jane Yallop,Steven McNulty,Linda Davidson Ray,Nancy E. Clapp-Channing,Yves Rosenberg,Eleanor Schron +19 more
TL;DR: For survivors of anterior-wall myocardial infarction who were not candidates for implantation of a cardioverter-defibrillator, access to a home AED did not significantly improve overall survival, as compared with reliance on conventional resuscitation methods.
Journal ArticleDOI
Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart Failure Results From the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
Daniel B. Mark,Charlotte L. Nelson,Kevin J. Anstrom,Sana M. Al-Khatib,Anastasios A. Tsiatis,Patricia A. Cowper,Nancy E. Clapp-Channing,Linda Davidson-Ray,Jeanne E. Poole,George Johnson,Jill Anderson,Kerry L. Lee,Gust H. Bardy +12 more
TL;DR: Prophylactic use of single-lead, shock-only I CD therapy is economically attractive in patients with stable, moderately symptomatic heart failure with an ejection fraction ≤35%, particularly those in NYHA class II, as long as the benefits of ICD therapy observed in the SCD-HeFT persist for at least 8 years.